Rosalind Advisors 13F annual report
Rosalind Advisors is an investment fund managing more than $107 billion ran by Steven Salamon. There are currently 31 companies in Mr. Salamon’s portfolio. The largest investments include Myomo Inc and Lyra Therapeutics, together worth $15.1 billion.
$107 billion Assets Under Management (AUM)
As of 5th July 2024, Rosalind Advisors’s top holding is 2,447,740 shares of Myomo Inc currently worth over $8 billion and making up 7.5% of the portfolio value.
Relative to the number of outstanding shares of Myomo Inc, Rosalind Advisors owns less than approximately 0.1% of the company.
In addition, the fund holds 1,144,524 shares of Lyra Therapeutics worth $7.12 billion, whose value fell 94.8% in the past six months.
The third-largest holding is MediWound Ltd worth $6.93 billion and the next is OptiNose Inc worth $6.63 billion, with 4,541,489 shares owned.
Currently, Rosalind Advisors's portfolio is worth at least $107 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Rosalind Advisors
The Rosalind Advisors office and employees reside in Toronto, Ontario, Canada. According to the last 13-F report filed with the SEC, Steven Salamon serves as the President, Rosalind Advisors, Inc. at Rosalind Advisors.
Recent trades
In the most recent 13F filing, Rosalind Advisors revealed that it had opened a new position in Myomo Inc and bought 2,447,740 shares worth $8 billion.
One of the smallest hedge funds
The two most similar investment funds to Rosalind Advisors are Sippican Capital Advisors and Eschler Asset Management LL.P.. They manage $126 billion and $127 billion respectively.
Steven Salamon investment strategy
Rosalind Advisors’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 78.6% of
the total portfolio value.
The fund focuses on investments in the United States as
51.6% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
35% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $215 million.
The complete list of Rosalind Advisors trades based on 13F SEC filings
These positions were updated on July 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Myomo Inc |
Opened
2,447,740
|
$8,004,110,000 | 7.48% |
| Lyra Therapeutics, Inc. |
Opened
1,144,524
|
$7,118,939,000 | 6.66% |
| MediWound Ltd |
Opened
485,990
|
$6,925,357,000 | 6.48% |
| OptiNose Inc |
Opened
4,541,489
|
$6,630,574,000 | 6.20% |
| Xeris Biopharma Holdings Inc |
Opened
2,820,170
|
$6,232,575,000 | 5.83% |
| COMPASS Pathways plc |
Opened
734,000
|
$6,106,880,000 | 5.71% |
| Cybin Inc |
Opened
13,960,000
|
$5,772,460,000 | 5.40% |
| Abivax Sa |
Opened
378,416
|
$5,411,348,000 | 5.06% |
| Viridian Therapeutics Inc |
Opened
300,000
|
$5,253,000,000 | 4.91% |
| Delcath Systems, Inc. |
Opened
1,038,828
|
$4,955,209,000 | 4.63% |
| Profound Medical Corp |
Opened
533,333
|
$4,549,330,000 | 4.25% |
| Verona Pharma Plc |
Opened
250,000
|
$4,022,500,000 | 3.76% |
| Clearside Biomedical Inc |
Opened
2,592,593
|
$3,966,667,000 | 3.71% |
| Outlook Therapeutics Inc |
Opened
311,775
|
$3,722,593,000 | 3.48% |
| KalVista Pharmaceuticals Inc |
Opened
287,985
|
$3,415,502,000 | 3.19% |
| Trevi Therapeutics, Inc. |
Opened
926,016
|
$3,194,755,000 | 2.99% |
| Veru Inc |
Opened
4,500,000
|
$3,150,450,000 | 2.95% |
| Unicycive Therapeutics Inc |
Opened
1,879,646
|
$2,593,911,000 | 2.43% |
| Cellectar Biosciences Inc |
Opened
621,478
|
$2,473,482,000 | 2.31% |
| PolyPid Ltd. |
Opened
415,800
|
$1,912,680,000 | 1.79% |
| InspireMD Inc |
Opened
686,062
|
$1,626,035,000 | 1.52% |
| Kiora Pharmaceuticals Inc |
Opened
2,300,000
|
$1,623,800,000 | 1.52% |
| Beyond Air, Inc. |
Opened
903,614
|
$1,572,288,000 | 1.47% |
| Cara Therapeutics Inc |
Opened
1,548,893
|
$1,409,493,000 | 1.32% |
| Fortress Biotech Inc |
Opened
607,797
|
$1,215,594,000 | 1.14% |
| Spruce Biosciences, Inc. |
Opened
1,508,419
|
$1,185,466,000 | 1.11% |
| Talphera Inc |
Opened
758,966
|
$781,735,000 | 0.73% |
| Biofrontera Inc |
Opened
504,261
|
$776,562,000 | 0.73% |
| Geron Corp. |
Opened
200,000
|
$660,000,000 | 0.62% |
| Rezolute Inc |
Opened
200,000
|
$510,000,000 | 0.48% |
| Tonix Pharma Hldg Crp |
Opened
900,900
|
$167,567,000 | 0.16% |
| No transactions found | |||
| Showing first 500 out of 31 holdings | |||
Hedge funds similar to Rosalind Advisors
- English Capital Management
- Piershale Financial Group, Inc
- Novak & Powell Services
- Tenret Co
- Mach-1
- Shorepath Capital Management
- Eschler Asset Management LL.P.
- Sippican Capital Advisors
- Continental Advisors
- Legend Advisors
- Alamar Capital Management
- Kiwi Wealth Investments Partnership
- Paces Ferry Wealth Advisors
- Client First Investment Management